Digital technologies are transforming infectious disease care, from AI-driven drug discovery and diagnostics to telemedicine, wearables, and adherence tools. These innovations promise faster and more equitable responses, bridging geographical and socioeconomic gaps, but raise challenges around bias, privacy, and access. This cross-journal Collection, a collaboration of Nature Communications, Nature Medicine, npj Digital Medicine, Communications Health and Communications Medicine, invites research on digital medicine solutions and best practices for infectious diseases to ensure safe, inclusive, and impactful implementation, as outlined in the Collection scope.
A Mon, study studied this question.